Key Insights

Highlights

Success Rate

85% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

6.9%

6 terminated out of 87 trials

Success Rate

85.0%

-1.5% vs benchmark

Late-Stage Pipeline

2%

2 trials in Phase 3/4

Results Transparency

12%

4 of 34 completed with results

Key Signals

4 with results85% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (22)
P 1 (10)
P 2 (16)
P 3 (1)
P 4 (1)

Trial Status

Completed34
Recruiting26
Active Not Recruiting9
Not Yet Recruiting7
Terminated6
Unknown4

Trial Success Rate

85.0%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (87)

Showing 20 of 20 trials
NCT07571499Not ApplicableNot Yet RecruitingPrimary

Helping Young People With Testicular Cancer Using Virtual and Extended Reality

NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT06193369Not ApplicableRecruiting

Digital Peer Navigation for Adolescents and Young Adults With Cancer

NCT05946993Not ApplicableActive Not Recruiting

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

NCT07124000Recruiting

DESTINY-PANTUMOUR04

NCT06814496Phase 1Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06702592Not ApplicableNot Yet RecruitingPrimary

Virtual Testis Cancer Lay Support and Survivorship Aim 2

NCT07407582Phase 1Not Yet Recruiting

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

NCT00034424CompletedPrimary

Cause of Familial Testicular Cancer

NCT06515613Phase 1Recruiting

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

NCT07498959Not ApplicableRecruitingPrimary

Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

NCT07406087Not ApplicableNot Yet Recruiting

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

NCT06593665Phase 3RecruitingPrimary

Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.

NCT07228637Not ApplicableActive Not RecruitingPrimary

Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer

NCT06828185Not ApplicableRecruitingPrimary

Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy

NCT06866964Phase 2Recruiting

A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

NCT06371768Not ApplicableRecruiting

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

NCT03937843Phase 2Active Not Recruiting

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

NCT07106827Phase 1Recruiting

A Study of GV20-0251 in Advanced or Refractory Solid Tumors

NCT03452774Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Scroll to load more

Research Network

Activity Timeline